Copyright Reports & Markets. All rights reserved.

Global Urokinase Solution Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Urokinase Solution Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Source of Human Urine
    • 1.3.3 Reorganization of Technical Production
  • 1.4 Market Analysis by Clinical Use
    • 1.4.1 Overview: Global Urokinase Solution Consumption Value by Clinical Use: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pulmonary Embolism Thrombolysis
    • 1.4.3 Deep Vein Thrombosis
    • 1.4.4 Peripheral Arterial Occlusion Thrombolysis
    • 1.4.5 Catheter / Cannula Occlusion Clearance
    • 1.4.6 Others
  • 1.5 Market Analysis by Administration Approach
    • 1.5.1 Overview: Global Urokinase Solution Consumption Value by Administration Approach: 2021 Versus 2025 Versus 2032
    • 1.5.2 Systemic Infusion
    • 1.5.3 Catheter-directed Thrombolysis (CDT)
    • 1.5.4 Intracatheter Dwell / Lock Technique
  • 1.6 Market Analysis by Purity
    • 1.6.1 Overview: Global Urokinase Solution Consumption Value by Purity: 2021 Versus 2025 Versus 2032
    • 1.6.2 Standard Clinical Grade
    • 1.6.3 High-purity / Low-impurity Grade
    • 1.6.4 Low Endotoxin / Low Bioburden Specifications
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Urokinase Solution Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Hospital
    • 1.7.3 Clinic
    • 1.7.4 Others
  • 1.8 Global Urokinase Solution Market Size & Forecast
    • 1.8.1 Global Urokinase Solution Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Urokinase Solution Sales Quantity (2021-2032)
    • 1.8.3 Global Urokinase Solution Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Syner-Med
    • 2.1.1 Syner-Med Details
    • 2.1.2 Syner-Med Major Business
    • 2.1.3 Syner-Med Urokinase Solution Product and Services
    • 2.1.4 Syner-Med Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Syner-Med Recent Developments/Updates
  • 2.2 Wanhua Biochem
    • 2.2.1 Wanhua Biochem Details
    • 2.2.2 Wanhua Biochem Major Business
    • 2.2.3 Wanhua Biochem Urokinase Solution Product and Services
    • 2.2.4 Wanhua Biochem Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Wanhua Biochem Recent Developments/Updates
  • 2.3 Jiangxi Haoran Bio-Pharma
    • 2.3.1 Jiangxi Haoran Bio-Pharma Details
    • 2.3.2 Jiangxi Haoran Bio-Pharma Major Business
    • 2.3.3 Jiangxi Haoran Bio-Pharma Urokinase Solution Product and Services
    • 2.3.4 Jiangxi Haoran Bio-Pharma Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Jiangxi Haoran Bio-Pharma Recent Developments/Updates
  • 2.4 Jiangsu Aidea Pharmaceutical
    • 2.4.1 Jiangsu Aidea Pharmaceutical Details
    • 2.4.2 Jiangsu Aidea Pharmaceutical Major Business
    • 2.4.3 Jiangsu Aidea Pharmaceutical Urokinase Solution Product and Services
    • 2.4.4 Jiangsu Aidea Pharmaceutical Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
  • 2.5 Techpool
    • 2.5.1 Techpool Details
    • 2.5.2 Techpool Major Business
    • 2.5.3 Techpool Urokinase Solution Product and Services
    • 2.5.4 Techpool Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Techpool Recent Developments/Updates
  • 2.6 Microbic Biosystems
    • 2.6.1 Microbic Biosystems Details
    • 2.6.2 Microbic Biosystems Major Business
    • 2.6.3 Microbic Biosystems Urokinase Solution Product and Services
    • 2.6.4 Microbic Biosystems Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Microbic Biosystems Recent Developments/Updates
  • 2.7 LIVZON
    • 2.7.1 LIVZON Details
    • 2.7.2 LIVZON Major Business
    • 2.7.3 LIVZON Urokinase Solution Product and Services
    • 2.7.4 LIVZON Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 LIVZON Recent Developments/Updates
  • 2.8 Wuhan Humanwell Pharma
    • 2.8.1 Wuhan Humanwell Pharma Details
    • 2.8.2 Wuhan Humanwell Pharma Major Business
    • 2.8.3 Wuhan Humanwell Pharma Urokinase Solution Product and Services
    • 2.8.4 Wuhan Humanwell Pharma Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Wuhan Humanwell Pharma Recent Developments/Updates
  • 2.9 Tianjin Biochem Pharma
    • 2.9.1 Tianjin Biochem Pharma Details
    • 2.9.2 Tianjin Biochem Pharma Major Business
    • 2.9.3 Tianjin Biochem Pharma Urokinase Solution Product and Services
    • 2.9.4 Tianjin Biochem Pharma Urokinase Solution Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Tianjin Biochem Pharma Recent Developments/Updates

3 Competitive Environment: Urokinase Solution by Manufacturer

  • 3.1 Global Urokinase Solution Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Urokinase Solution Revenue by Manufacturer (2021-2026)
  • 3.3 Global Urokinase Solution Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Urokinase Solution by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Urokinase Solution Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Urokinase Solution Manufacturer Market Share in 2025
  • 3.5 Urokinase Solution Market: Overall Company Footprint Analysis
    • 3.5.1 Urokinase Solution Market: Region Footprint
    • 3.5.2 Urokinase Solution Market: Company Product Type Footprint
    • 3.5.3 Urokinase Solution Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Urokinase Solution Market Size by Region
    • 4.1.1 Global Urokinase Solution Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Urokinase Solution Consumption Value by Region (2021-2032)
    • 4.1.3 Global Urokinase Solution Average Price by Region (2021-2032)
  • 4.2 North America Urokinase Solution Consumption Value (2021-2032)
  • 4.3 Europe Urokinase Solution Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Urokinase Solution Consumption Value (2021-2032)
  • 4.5 South America Urokinase Solution Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Urokinase Solution Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Urokinase Solution Sales Quantity by Type (2021-2032)
  • 5.2 Global Urokinase Solution Consumption Value by Type (2021-2032)
  • 5.3 Global Urokinase Solution Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Urokinase Solution Sales Quantity by Application (2021-2032)
  • 6.2 Global Urokinase Solution Consumption Value by Application (2021-2032)
  • 6.3 Global Urokinase Solution Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Urokinase Solution Sales Quantity by Type (2021-2032)
  • 7.2 North America Urokinase Solution Sales Quantity by Application (2021-2032)
  • 7.3 North America Urokinase Solution Market Size by Country
    • 7.3.1 North America Urokinase Solution Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Urokinase Solution Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Urokinase Solution Sales Quantity by Type (2021-2032)
  • 8.2 Europe Urokinase Solution Sales Quantity by Application (2021-2032)
  • 8.3 Europe Urokinase Solution Market Size by Country
    • 8.3.1 Europe Urokinase Solution Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Urokinase Solution Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Urokinase Solution Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Urokinase Solution Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Urokinase Solution Market Size by Region
    • 9.3.1 Asia-Pacific Urokinase Solution Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Urokinase Solution Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Urokinase Solution Sales Quantity by Type (2021-2032)
  • 10.2 South America Urokinase Solution Sales Quantity by Application (2021-2032)
  • 10.3 South America Urokinase Solution Market Size by Country
    • 10.3.1 South America Urokinase Solution Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Urokinase Solution Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Urokinase Solution Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Urokinase Solution Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Urokinase Solution Market Size by Country
    • 11.3.1 Middle East & Africa Urokinase Solution Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Urokinase Solution Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Urokinase Solution Market Drivers
  • 12.2 Urokinase Solution Market Restraints
  • 12.3 Urokinase Solution Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Urokinase Solution and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Urokinase Solution
  • 13.3 Urokinase Solution Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Urokinase Solution Typical Distributors
  • 14.3 Urokinase Solution Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Urokinase Solution market size was valued at US$ 7.60 million in 2025 and is forecast to a readjusted size of US$ 10.74 million by 2032 with a CAGR of 5.0% during review period.
    Urokinase Solution is a clot-dissolving medicine. It is a natural enzyme (a protein) that activates the body’s own fibrinolytic system by converting plasminogen into plasmin, and plasmin then breaks down fibrin, which is the “mesh” that holds a blood clot together. This is why urokinase is called a thrombolytic or “clot-buster.” The market for urokinase mainly includes injectable products (usually a sterile powder that is dissolved before use) that are given in hospitals, either through a vein or through a catheter directly to the clot area, depending on the indication and local practice. The clinical risk that shapes this market is also simple: because the drug dissolves clots, it can also weaken normal clotting at injury sites, so bleeding is the key safety concern and a major reason urokinase is used in controlled hospital settings.
    In 2025, global Urokinase Solution production reached approximately 254.8 BIU, with an average global market price of around US$ 29 per MIU. The global single-line production capacity ranges from 10 to 15 BIU per year. The industry's gross profit margin is approximately 25%-35%.
    This report is a detailed and comprehensive analysis for global Urokinase Solution market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Urokinase Solution market size and forecasts, in consumption value ($ Million), sales quantity (BIU), and average selling prices (USD/MIU), 2021-2032
    Global Urokinase Solution market size and forecasts by region and country, in consumption value ($ Million), sales quantity (BIU), and average selling prices (USD/MIU), 2021-2032
    Global Urokinase Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (BIU), and average selling prices (USD/MIU), 2021-2032
    Global Urokinase Solution market shares of main players, shipments in revenue ($ Million), sales quantity (BIU), and ASP (USD/MIU), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Urokinase Solution
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Urokinase Solution market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems, LIVZON, Wuhan Humanwell Pharma, Tianjin Biochem Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Urokinase Solution market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Source of Human Urine
    Reorganization of Technical Production
    Market segment by Clinical Use
    Pulmonary Embolism Thrombolysis
    Deep Vein Thrombosis
    Peripheral Arterial Occlusion Thrombolysis
    Catheter / Cannula Occlusion Clearance
    Others
    Market segment by Administration Approach
    Systemic Infusion
    Catheter-directed Thrombolysis (CDT)
    Intracatheter Dwell / Lock Technique
    Market segment by Purity
    Standard Clinical Grade
    High-purity / Low-impurity Grade
    Low Endotoxin / Low Bioburden Specifications
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Syner-Med
    Wanhua Biochem
    Jiangxi Haoran Bio-Pharma
    Jiangsu Aidea Pharmaceutical
    Techpool
    Microbic Biosystems
    LIVZON
    Wuhan Humanwell Pharma
    Tianjin Biochem Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Urokinase Solution product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Urokinase Solution, with price, sales quantity, revenue, and global market share of Urokinase Solution from 2021 to 2026.
    Chapter 3, the Urokinase Solution competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Urokinase Solution breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Urokinase Solution market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Urokinase Solution.
    Chapter 14 and 15, to describe Urokinase Solution sales channel, distributors, customers, research findings and conclusion.

    Buy now